REFERENCES
The US National Nanotechnology Initiative (NNI). http://www.nano.gov/html/about/home_about.html.
Buzea C, Pacheco Blandino II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2007;2(4):MR17–172.
Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823–39.
Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nano. 2009;4:747–51.
U.S. Food and Drug Administration, Nanotechnology Task Force Report. July 2007. http://www/fda.gov/nanotechnology/taskforce/report2007.html.
Padamwar MN, Pokharkar VB. Development of vitamin loaded liposomal formulations using factorial design approach: drug deposition and stability. Int J Pharm. 2006;320:37–44.
Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. J Pharm Sci. 1994;83(9):1189–203.
Lens M. Use of fullerenes in cosmetics. Recent Patents on Biotechnology. 2009;3:118–23.
Petersen R. Nanocrystals for use in topical cosmetic formulations and method of production thereof. Abbott GmbH & Co. US Patent 60/866233 (2008).
L’Oréal. Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics. US Patent 6432423, (2002).
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–84.
Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427–43.
Villalobos-Hernàndez JR, Müller-Goymann CC. Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: The synergistic interaction between organic and inorganic sunscreens at nanoscale. Int J Pharm. 2006;322:161–70.
Friends of the Earth. http://www.foe.org. Nanomaterials, sunscreens and cosmetics: Small Ingredients, Big Risks, (2006).
Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007;20:10–20.
Jowsey IR, Basketter DA, Westmoreland C, Kimber IA. A future approach to measuring relative skin sensitising potential: a proposal. J Appl Toxicol. 2006;26(4):341–50.
Disclaimer
The views expressed in this commentary are those of the author(s) alone. They do not represent the views or opinions of the US FDA or any entity of or affiliated with the US FDA. The contents of this commentary do not imply an endorsement or disapproval of the use of the nanomaterials mentioned herein.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mu, L., Sprando, R.L. Application of Nanotechnology in Cosmetics. Pharm Res 27, 1746–1749 (2010). https://doi.org/10.1007/s11095-010-0139-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0139-1